NASDAQ:ALKS • IE00B56GVS15
This ALKS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
Overall ALKS gets a fundamental rating of 6 out of 10. We evaluated ALKS against 519 industry peers in the Biotechnology industry. ALKS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ALKS is not valued too expensively and it also shows a decent growth rate. With these ratings, ALKS could be worth investigating further for quality investing!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.72% | ||
| ROE | 13.28% | ||
| ROIC | 10.9% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.21% | ||
| PM (TTM) | 16.37% | ||
| GM | 86.69% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 5.34 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.55 | ||
| Quick Ratio | 3.19 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.91 | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.5 | ||
| EV/EBITDA | 13.66 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:ALKS (3/12/2026, 2:15:19 PM)
27.37
-0.4 (-1.44%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.91 | ||
| Fwd PE | N/A | ||
| P/S | 3.09 | ||
| P/FCF | 9.5 | ||
| P/OCF | 8.76 | ||
| P/B | 2.51 | ||
| P/tB | 2.63 | ||
| EV/EBITDA | 13.66 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.72% | ||
| ROE | 13.28% | ||
| ROCE | 13.07% | ||
| ROIC | 10.9% | ||
| ROICexc | 15.63% | ||
| ROICexgc | 16.66% | ||
| OM | 17.21% | ||
| PM (TTM) | 16.37% | ||
| GM | 86.69% | ||
| FCFM | 32.55% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 148.79% | ||
| Cap/Sales | 2.74% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 185.24% | ||
| Profit Quality | 198.76% | ||
| Current Ratio | 3.55 | ||
| Quick Ratio | 3.19 | ||
| Altman-Z | 5.34 |
ChartMill assigns a fundamental rating of 6 / 10 to ALKS.
ChartMill assigns a valuation rating of 5 / 10 to ALKERMES PLC (ALKS). This can be considered as Fairly Valued.
ALKERMES PLC (ALKS) has a profitability rating of 7 / 10.
The Earnings per Share (EPS) of ALKERMES PLC (ALKS) is expected to decline by -135.86% in the next year.